药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Enprofylline
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Mitoxantrone.
Enprofylline
Roflumilast
Roflumilast may increase the immunosuppressive activities of Mitoxantrone.
Enprofylline
Difluocortolone
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Difluocortolone.
Enprofylline
Clobetasol
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Clobetasol.
Enprofylline
Fluocortolone
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluocortolone.
Enprofylline
Hydrocortisone butyrate
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Hydrocortisone butyrate.
Enprofylline
Fluocinonide
The risk or severity of adverse effects can be increased when Fluocinonide is combined with Mitoxantrone.
Enprofylline
Clobetasol propionate
The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Mitoxantrone.
Enprofylline
Belinostat
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Belinostat.
Enprofylline
Trilostane
The risk or severity of adverse effects can be increased when Trilostane is combined with Mitoxantrone.
Enprofylline
Budesonide
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Budesonide.
Enprofylline
Bleselumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Bleselumab.
Enprofylline
Rozanolixizumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Rozanolixizumab.
Enprofylline
Risankizumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Risankizumab.
Enprofylline
Emapalumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Emapalumab.
Enprofylline
Hydrocortisone succinate
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Hydrocortisone succinate.
Enprofylline
Hydrocortisone acetate
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Hydrocortisone acetate.
Enprofylline
Mometasone furoate
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Mometasone furoate.
Enprofylline
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Monomethyl fumarate.
Enprofylline
Tetrandrine
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Tetrandrine.